These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2966803)

  • 41. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM; D'Souza UM; Strange PG
    J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
    Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
    Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine receptors in human foetal brains: characterization, regulation and ontogeny of [3H]spiperone binding sites in striatum.
    Kumar BV; Sastry PS
    Neurochem Int; 1992 Jun; 20(4):559-66. PubMed ID: 1304871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor.
    Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1987 Nov; 36(22):3903-10. PubMed ID: 2961340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 47. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
    Niznik HB; Grigoriadis DE; Seeman P
    FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes.
    Vaccari A; Gessa G
    Neurochem Res; 1989 Oct; 14(10):949-55. PubMed ID: 2532713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of organophosphates on dopamine and muscarinic receptor binding in rat brain.
    Naseem SM
    Biochem Int; 1990; 20(4):799-806. PubMed ID: 2141256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4-[123I]iodospiperone as a ligand for dopamine DA receptors: in vitro and in vivo experiments in a rat model.
    Van der Krogt JA; Pauwels EK; Van Doremalen PA; Wijnhoven G; Reiffers S; Van Valkenburg CF; Buruma OJ
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):759-63. PubMed ID: 1399697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo.
    Dorris RL
    Proc Soc Exp Biol Med; 1987 Oct; 186(1):13-6. PubMed ID: 3628250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
    Clagett-Dame M; McKelvy JF
    Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M; Hall JM; Frankham PA; Strange PG
    J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A re-evaluation of changes in rat striatal D-2 dopamine receptors during development and aging.
    O'Boyle KM; Waddington JL
    Neurobiol Aging; 1986; 7(4):265-7. PubMed ID: 2944023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum.
    Govoni S; Di Giovine S; Moresco RM; Battaini F; Trabucchi M
    Neurosci Lett; 1988 Apr; 87(1-2):173-7. PubMed ID: 3380334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ; Reches A; MacLeod RM; Login IS
    Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific in vivo binding of 3H-spiperone to individual lobes of the pituitary gland of the rat. Evidence for the labelling of dopamine receptors.
    Köhler C; Fahlberg K
    J Neural Transm; 1985; 63(1):39-52. PubMed ID: 4031846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK; Lai JC; Lim L
    Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
    Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice.
    Kaseda Y; Ghetti B; Low WC; Richter JA; Simon JR
    Brain Res; 1987 Sep; 422(1):178-81. PubMed ID: 2960423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.